Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 208-144-8 | CAS number: 512-56-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
A reverse gene mutation assay was conducted in line with Guidelines for Screening Mutagenicity Testing of Chemicals (Japan) and OECD Test Guidelines 471 and 472, using the pre-incubation method. Trimethyl phosphate showed negative results in Salmonella typhimurium TA100, TA1535, TA98, TA1537 and Escherichia coli WP2 uvrA at concentrations up to 5 mg/plate with or without a metabolic activation system (MHW, 1993).
In a supporting gene mutation assay conducted by Zeiger et al. 1992 comparable to the guideline OECD 471 with acceptable restictions only Salmonella typhimurium TA 98 and TA100 were used. The test was positive with Salmonella typhimurium strain TA100 after metabolic activation.
A chromosomal aberration test in line with Guidelines for Screening Mutagenicity Testing of Chemicals (Japan) and OECD Test Guideline 473 was conducted using cultured Chinese Hamster lung (CHL/IU) cells. Cytotoxic effects were seen at 1.4 mg/ml. In the short term treatment, it was set to 3.5 mg/ml because the concentration was equivalent to ca. 10 mM as required in test guidelines.
Cytogenetic effects were not seen under the conditions of this experiment. Neither structural chromosomal aberrations nor polyploidy were induced up to the limit concentration of 10 mM, in the absence or presence of an exogenous metabolic activation system in CHL/IU cells. (MHW, Japan, 1994).
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Description of key information
In the micronuclei test of Weber et al. (1975) 5 B6D2F1/j mice per group were exposed for 5 consecutive days to 0, 500, 750, 1000 or 2000 mg/kg bw/day. Under the experimental conditions of this study, in metaphase analysis, trimethyl phosphate was found to increase the break frequency between 0.5 and 0.75 g/kg. No other aberreation other than chromatid breaks was observed.
In micronuclei test an increasing response was found at doses between 0.5 and 1 g/kg. The highest dose of 2 g/kg was lethal.
In intreperitoneal dominant lethal and heritable translocation studies mice were exposed to 1000, 1250 and 1500 mg/kg bw/day.
In the dominant lethal assay, each male was mated with 2 virgin females for 1 week from day 7. Females were checked for the presence of vaginal plugs every morning. They were sacrificed 12 - 15 days after conception to analyze uterine contents.
No significant differences were found between control and test groups in the number of corpora lutea. Significant decreases in the number of implants and living embryos were however found, and the number of early fetal deaths in the TMP test groups increased with the dose.
In the heritable translocation study, seven days after the injection, each male was mated with 2 untreated females for a period of 1 week. Litter sizes were determined at birth and at weaning. No significant differences were found in the frequency of fertile females between the control and TMP groups but a marked decrease was observed in the MMS group. There were significant decreases in the number of live young at birth in all test groups compared with the control. These results suggest that there would be marked increases in the frequency of pre- and post-implantation losses in these test groups.
The frequency of dominant lethal mutations estimated from the mean litter size at birth in each test group was 13.0% (lower TMP dose), 51.2% (higher TMP dose) or 57.6% (MMS). The difference between the frequency from the lower dose in this study and that in the dominant lethal assay might be due to the small number of matings in the dominant lethal test. Based upon male progeny only a slight but significant reduction in the number of young weaned was observed in the TMP high dose group. Since litter sizes were adjusted to 4 or more at the time of birth, any loss of young due to insufficient stimulus of lactation of the female could be avoided. Thus the result suggests that TMP treatment of males using a dose of 1 500 mg/kg resulted in a decrease in viability of their male offspring. After weaning, 4 animals in the higher TMP dose group and 3 in the MMS group died because of weakness or by accident.
The present data clearly show that TMP is capable of inducing chromosomal breakage in mouse post-meiotic germ cells (spermatids). The breakage induced includes heritable translocations. The incidence of translocations observed in the higher TMP dose group was comparable to that in the MMS group (50 mg/kg dose). A clear-cut and dose-dependent increase in translocation induction was observed with TMP exposure.
In a comet assay CD-1 mice were exposed to 0, 125, 250 or 500 mg/kg bw/day per gavage. Testicular cells were examined using the alkaline version of the Comet assay and the DNA damage was quantified as % tail DNA using a fully automatic scoring system. There were five animals in each dose group and 200 cells were scored for each mouse. Data were analyzed by means of a linear mixed-effects model with Dunnett’s test to compare the dose groups to their corresponding control. The results show significant DNA strand breaking effects (% tail DNA after administration) in the dose group of 500 mg/kg bw/day. (Hansen et al., 2004).
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (positive)
Additional information
Studies on in vitro genotoxicity showed heterogenous effects (Ames-Tests, Chromosome aberration test) while the in vivo genetic toxicity tests (Comet Assay, Dominant Lethal Assay and Heritable translocation study, Micronucleus Test) were consistently positive.
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.